Concepedia

L. Wright

LW

Statistics

Publications

5

Citations

408

H-Index

5

Active since

2003

Affiliations

Alvin J. Siteman Cancer Center(Current)

Washington University in St. Louis

National Institutes of Health

National Cancer Institute

Jewish Hospital

L. Wright is an author at Alvin J. Siteman Cancer Center specializing in pharmacology, pharmacokinetics of anticancer agents, and pharmacokinetics of anticancer drugs.

Publications per year

2003–2010

5

Publications

5

A Phase 1 Escalating Single-Dose and Weekly Fixed-Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing

Paula M. Fracasso, Howard A. Burris, Matthew A. Arquette et al. · Clinical Cancer Research · 2007 · 149 citations

, , +17

Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia

Francis J. Giles, Paula M. Fracasso, Hagop M. Kantarjian et al. · Leukemia Research · 2003 · 92 citations

, , +5

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies

Paula M. Fracasso, Kerry J. Williams, Ronald C. Chen et al. · Cancer Chemotherapy and Pharmacology · 2010 · 70 citations · Full text

, , +17

Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies

Paula M. Fracasso, Lori J. Goldstein, Dinesh P. de Alwis et al. · Clinical Cancer Research · 2004 · 70 citations

, , +17

Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

Paula M. Fracasso, Kristie A. Blum, Mitra Subrata k et al. · British Journal of Cancer · 2005 · 27 citations · Full text

, , +17

1–5 of 5